Trial Profile
A Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Edaravone + (+)-Borneol When Administered Intravenously in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 May 2018
Price :
$35
*
At a glance
- Drugs Borneol/edaravone (Primary)
- Indications Stroke
- Focus Adverse reactions
- Sponsors Medpace
- 11 May 2018 New trial record